Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

NCT00687622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: GSK1120212

Sponsor

GlaxoSmithKline